Works cited by this work

100 works

Work: Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

1. NK Cells in the Treatment of Hematological Malignancies

   Ana Pilar González, Mónica Villa-Álvarez, Christian Sordo‐Bahamonde +2

   Review article20192 citations

   ABIABI:AkademIndex/openalex/2026.other.840989

2. Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives

   Chenyang Jiang, Hao Sun, Zhongxing Jiang +3

   Review article20242 citations

   ABIABI:AkademIndex/openalex/2026.other.841034

3. The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment

   Maximilian Haist, Henner Stege, Stephan Grabbe +1

   Review article20212 citations

   ABIABI:AkademIndex/openalex/2026.other.860191

4. Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products

   Muhammad Sadeqi Nezhad, Meghdad Abdollahpour‐Alitappeh, Behzad Rezaei +2

   Review article20212 citations

   ABIABI:AkademIndex/openalex/2026.other.860196

5. Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients

   Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh +3

   Review article20222 citations

   ABIABI:AkademIndex/openalex/2026.other.860210

6. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.860176

7. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.860177

8. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.860178

9. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.860179

10. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860180

11. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860181

12. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860182

13. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860183

14. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860184

15. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860185

16. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860186

17. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860187

18. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860188

19. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860189

20. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860190

21. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860192

22. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860193

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860194

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860195

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.860197